A systematic review of 22 studies found medical cannabis may be safe and effective for fibromyalgia pain, with THC/CBD ratio determining effects on different symptoms, but dosing and long-term data are lacking.
Fibromyalgia patients, rheumatologists, and pain management clinicians.
22 studies reviewed across multiple cannabinoid formulations
What the researchers found
Across 22 studies, medical cannabis (including nabilone, dronabinol, and various THC/CBD ratios) showed analgesic and anti-inflammatory effects in fibromyalgia patients. The THC-to-CBD ratio influenced which symptoms improved most. Studies used products including nabilone, dronabinol, Bedrocan (22.4mg THC), Bediol (13.4mg THC + 17.8mg CBD), and Bedrolite (18.4mg CBD).
Why it matters
Fibromyalgia affects millions and current FDA-approved treatments have limited effectiveness. Cannabis represents a potential alternative, particularly as the opioid crisis makes non-opioid pain options increasingly important.
The numbers in context
22 articles included. Formulations studied: nabilone, dronabinol, Bedrocan (22.4mg THC, <1mg CBD), Bediol (13.4mg THC, 17.8mg CBD), Bedrolite (18.4mg CBD, <1mg THC). THC/CBD ratio influenced symptom-specific effects.
How the study worked
Systematic review following PRISMA guidelines. Searched PubMed, MEDLINE, PubMed Central, and Google Scholar. 22 articles met inclusion criteria after quality assessment. Analyzed the role of cannabis in fibromyalgia treatment across different cannabinoid formulations.
What this study cannot tell us
Heterogeneous study designs across the 22 included studies. Limited data on optimal dosing, treatment duration, adverse effects, and long-term outcomes. Many studies were small or observational.
How to read the evidence
Systematic review with PRISMA methodology, but underlying studies were heterogeneous and often small.
When this study was published
2021 systematic review.
The bigger picture
The finding that different THC/CBD ratios affect different fibromyalgia symptoms suggests that a one-size-fits-all approach to medical cannabis for fibromyalgia is unlikely to work. Personalized formulation selection may be key to optimizing outcomes.
Questions still open
- What is the optimal THC/CBD ratio for different fibromyalgia symptoms? What are the long-term effects and dependence risks? How does medical cannabis compare to approved fibromyalgia medications in head-to-head trials?
Common questions
Does medical cannabis work for fibromyalgia?
Which cannabis formulation is best for fibromyalgia?
Read the original research
A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?
Cureus, 13(8), e17332
Citation
Khurshid, Hajra; Qureshi, Israa A; Jahan, Nasrin; Went, Terry R; Sultan, Waleed; Sapkota, Alisha; Alfonso, Michael. (2021). A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?. Cureus, 13(8), e17332. https://doi.org/10.7759/cureus.17332
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk